3P BIOPHARMACEUTICALS SL - Spain 

Ranking results:

Past rankings:

2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2013 0 3.872.919 754.961 1
2012 0 5.976.298 398.420 1

Networking:

Project overview:

Start dateProjectacronymrolefundingpartners
2013-09-01Development of a universal influenza vaccine based on tandem core technology FLUTCOREparticipant3.872.9197
2012-11-01"Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD)" TARGETAMDparticipant5.976.29815